Matthew Bross Email

Administrative Specialist . ILiAD Biotechnologies

Current Roles

Employees:
24
Revenue:
$1.9M
About
ILiAD Biotechnologies is utilizing its B-Tech vector platform to develop next generation vaccines to eradicate infectious diseases and improve lives. Its lead candidate, BPZE1, which has completed Phase 2 clinical trials, is the most advanced next generation vaccine for the prevention of whooping cough, a serious illness caused by Bordetella pertussis.
ILiAD Biotechnologies Address
4581 Weston Road
Weston, FL
ILiAD Biotechnologies Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.